Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2005 filings

All 33 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2005, sourced directly from the official regulator.

33 Filings
2005 Period
2005 filings (33)
Filing Released Lang
CEO presenting at US Healthcare Conference 15 pages ?Kb
Investor Presentation
2005-11-08 English
Appendix 3B - Exercise of Options 8 pages ?Kb
Capital/Financing Update
2005-11-02 English
Annual General Meeting Results 2 pages ?Kb
Regulatory Filings
2005-10-19 English
Chairman's Address & Managing Directors Presentation 19 pages ?Kb
AGM Information
2005-10-18 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-10-13 English
Resignation of Development Director 1 page ?Kb
Board/Management Information
2005-10-12 English
Results of ATL1101 Proof of Concept study 2 pages ?Kb
Regulatory Filings
2005-10-03 English
Annual Report & Notice of AGM 53 pages ?Kb
Regulatory Filings
2005-09-13 English
Animal data supports potential of ATL1103 in eye diseases 3 pages ?Kb
Regulatory Filings
2005-09-11 English
To submit application to restart ATL1102 Phase IIA Trial 7 pages ?Kb
Regulatory Filings
2005-08-30 English
CorrectCopy/To submit app. to restart ATL1102Phase IIa Trial 7 pages ?Kb
Regulatory Filings
2005-08-30 English
Preliminary Final Report/Full Year Accounts 39 pages ?Kb
Annual Report
2005-08-11 English
Trading Halt 1 page ?Kb
Regulatory Filings
2005-08-10 English
Response to ASX Share Price Query 5 pages ?Kb
Regulatory Filings
2005-08-10 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-07-20 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-07-06 English
Appendix 3B - Employee Options 9 pages ?Kb
Regulatory Filings
2005-07-06 English
Results of General Meeting 1 page ?Kb
Regulatory Filings
2005-06-26 English
Letter to Shareholders/Notice of AGM 12 pages ?Kb
Proxy Solicitation & Information Statement
2005-05-24 English
Asthma data presented at American Thoracic Society Meeting 2 pages ?Kb
Investor Presentation
2005-05-22 English
Company Update 4 pages ?Kb
Capital/Financing Update
2005-05-17 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-04-18 English
Asthma Data On Inhaled Drug to be Presented at Conference 9 pages ?Kb
Investor Presentation
2005-03-20 English
Progress Report Halts ATL1102 Phase 2a MS Trial 1 p
Regulatory Filings
2005-03-09 English
Trading Halt 1 page ?Kb
Regulatory Filings
2005-02-28 English
Market Update 1 page ?Kb
Regulatory Filings
2005-02-28 English
Antisense inhibition of VLA4 in mouse model of MS published 2 pages ?Kb
Regulatory Filings
2005-02-24 English
Appendix 3B-exercise of options 8 pages ?Kb
Share Issue/Capital Change
2005-02-21 English
US Presentations 21 pages ?Kb
Investor Presentation
2005-02-17 English
Half Yearly Report & Half Year Accounts 19 pages ?Kb
Interim / Quarterly Report
2005-02-16 English
Investor Update 6 pages ?Kb
Investor Presentation
2005-02-01 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-01-19 English
Antisense Therapeutics Establishes Level 1 US ADR Program 1
Regulatory Filings
2005-01-12 English